The encouraging antitumor results from the combination of vitamin E treatment and adoptive immunotherapy consisting of antigen-specific CD8+ T cells suggest that vitamin E treatment may also be used in conjunction with active immunization with antigen-specific tumor vaccines to generate potent antitumor effects. Here, CD8A is linked to neoplasm.